Get the Stockscreener App
28.63
0.24%
-0.07
Rigel Pharmaceuticals stock is traded at $28.63, with a volume of 700.39K.
It is down -0.24% in the last 24 hours and down -31.21% over the past month.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
See More
Previous Close:
$28.70
Open:
$28.61
24h Volume:
700.39K
Relative Volume:
1.20
Market Cap:
$513.55M
Revenue:
$116.88M
Net Income/Loss:
$-25.09M
P/E Ratio:
-204.50
EPS:
-0.14
Net Cash Flow:
$-20.74M
1W Performance:
-17.54%
1M Performance:
-31.21%
6M Performance:
+50.84%
1Y Performance:
+78.94%
1-Day Range:
$27.90
$29.00
1-Week Range:
$27.90
$36.05
52-Week Range:
$13.57
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Name
Rigel Pharmaceuticals
Sector
Industry
Phone
650-624-1100
Address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Compare RIGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
28.63 | 514.80M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.74 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.90 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.40 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.62 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.06 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-23 | Resumed | Piper Sandler | Neutral |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Jun-08-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-23-22 | Initiated | B. Riley Securities | Neutral |
| Nov-09-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-15-19 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-26-19 | Resumed | JP Morgan | Overweight |
| Mar-01-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Aug-27-18 | Initiated | Citigroup | Buy |
| May-02-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Resumed | Piper Jaffray | Overweight |
| Dec-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-06-17 | Resumed | H.C. Wainwright | Buy |
| Mar-09-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-31-16 | Reiterated | H.C. Wainwright | Buy |
| Aug-30-16 | Reiterated | Piper Jaffray | Overweight |
| Jul-13-16 | Initiated | H.C. Wainwright | Buy |
| Jun-13-16 | Initiated | Piper Jaffray | Overweight |
| Apr-22-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-08-13 | Reiterated | Stifel | Buy |
| Nov-29-12 | Initiated | UBS | Neutral |
| Nov-06-12 | Reiterated | Oppenheimer | Outperform |
| Mar-26-12 | Initiated | Canaccord Genuity | Hold |
| Dec-10-10 | Downgrade | MP Advisors | Outperform → Market Perform |
View All
Rigel Pharmaceuticals Stock (RIGL) Latest News
What analysts say about Rigel Pharmaceuticals Inc RI2 stockBollinger Bands Signals & High Profit Market Growth - Early Times
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - sharewise.com
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking Alpha
RIGL vs. FOLD: Which Biotech Stock Offers Better Growth Potential? - Yahoo Finance
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? - simplywall.st
Benign Growth For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Underpins Stock's 26% Plummet - simplywall.st
Strs Ohio Takes Position in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Voya Investment Management LLC Sells 22,411 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Goldman Sachs Group Inc. Sells 107,461 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 4.9%What's Next? - MarketBeat
Earnings Miss: Is Rigel Pharmaceuticals Inc attractive at current valuationMarket Risk Summary & Fast Entry and Exit Trade Plans - خودرو بانک
Aug Highlights: Can Rigel Pharmaceuticals Inc continue delivering strong returns2025 Market WrapUp & Weekly Stock Breakout Alerts - khodrobank.com
Movement Recap: Can Rigel Pharmaceuticals Inc. continue delivering strong returnsProduct Launch & Real-Time Market Sentiment Alerts - خودرو بانک
Aug Breakouts: Can Rigel Pharmaceuticals Inc continue delivering strong returnsInsider Selling & Short-Term Trading Opportunity Alerts - khodrobank.com
Aug Update: What is the Moat Score of Rigel Pharmaceuticals Inc2025 Market Sentiment & Free Accurate Trade Setup Notifications - خودرو بانک
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - TradingView
Rigel Pharmaceuticals Experiences Valuation Adjustment Amid Strong Financial Metrics and Market Position - Markets Mojo
Acadian Asset Management LLC Buys 188,679 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - MSN
Rigel Pharmaceuticals Sees Valuation Upgrade Amid Strong Financial Performance and Growth - Markets Mojo
Aug Swings: Is Waters Corporation a strong growth stock2025 Sector Review & Fast Moving Trade Plans - خودرو بانک
Dynamic Technology Lab Private Ltd Purchases Shares of 27,117 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals Achieves 172.26% Return, Marking It as a Multibagger in Biotechnology Sector - Markets Mojo
Trading Action: Is Rigel Pharmaceuticals Inc attractive at current valuation2025 Market WrapUp & Weekly Stock Breakout Alerts - خودرو بانک
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $38.20 Consensus Price Target from Analysts - MarketBeat
Jacobs Levy Equity Management Inc. Buys 15,687 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? - MSN
Short Interest in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Declines By 20.7% - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 6.1%Here's Why - MarketBeat
What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - sharewise.com
A Look At The Intrinsic Value Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Yahoo Finance
Is Rigel Pharmaceuticals Inc.’s growth already priced inMarket Risk Summary & Reliable Volume Spike Alerts - beatles.ru
Rafferty Asset Management LLC Purchases Shares of 21,397 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Can Rigel Pharmaceuticals Inc. continue delivering strong returnsQuarterly Profit Review & Free Long-Term Investment Growth Plans - خودرو بانک
Price momentum metrics for Rigel Pharmaceuticals Inc. explained2025 Stock Rankings & Real-Time Volume Triggers - Newser
Can Rigel Pharmaceuticals Inc. lead its sector in growth2025 Investor Takeaways & Long-Term Safe Return Strategies - خودرو بانک
Charles Schwab Investment Management Inc. Has $1.19 Million Stock Holdings in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Do Options Traders Know Something About RIGL Stock We Don't? - sharewise.com
What’s the MACD signal for Rigel Pharmaceuticals Inc.Trade Performance Summary & High Conviction Buy Zone Picks - خودرو بانک
Using data models to predict Rigel Pharmaceuticals Inc. stock movementMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
What earnings revisions data tells us about Rigel Pharmaceuticals Inc.Options Play & Community Consensus Picks - Newser
Will Rigel Pharmaceuticals Inc. bounce back from current supportJuly 2025 Decliners & Target Return Focused Picks - Newser
Technical analysis overview for Rigel Pharmaceuticals Inc. stockJuly 2025 Closing Moves & High Return Stock Watch Alerts - Newser
Rigel Pharmaceuticals Stock (RIGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rigel Pharmaceuticals Stock (RIGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schorno Dean L | EVP & Chief Financial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,734 |
38,020 |
57,235 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 04 '25 |
Sale |
20.92 |
2,125 |
44,457 |
53,500 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,796 |
39,379 |
51,704 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 04 '25 |
Sale |
20.92 |
4,952 |
103,601 |
243,854 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 05 '25 |
Sale |
21.93 |
4,400 |
96,474 |
239,454 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 04 '25 |
Sale |
20.92 |
1,448 |
30,294 |
40,169 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 05 '25 |
Sale |
21.93 |
1,339 |
29,359 |
38,830 |
3.41%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):